XLV241220C145500
- 0.07
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
Merck Decides To End Favezelimab Clinical Development Program, And Stop Enrollment In Phase 3 KEYFORM-008 Trial
Ease up on Mag 7, ''Trump Trade' Exposure as Inflation Flare-up Looms: MS Wealth Mgmt
Moderna Remains the Most Shorted Among S&P 500 Healthcare Stocks in November
Trump Targets PBMs in Comments at Mar-a-Lago
9 Health Care Stocks With Whale Alerts In Today's Session
Weekly ETF Flows: Six Out of 11 Sectors Record Outflows, Bitcoin Continues to Lead With Higher Inflows
$100 Invested In Intuitive Surgical 5 Years Ago Would Be Worth This Much Today
Another Week, Another Index Record | Lkive Stock
Sector Update: Health Care Stocks Mixed Pre-Bell Monday
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Federal Reserve Policy Meeting
UnitedHealth Down 15% Amid Grief, Anger, and Frustration After Shooting
Insider Trades: Kroger, Johnson & Johnson Among Notable Names This Week
Negative Market Breadth, Hot Inflation Data Snaps S&P 500's Three-week Win Streak
Weekly Buzz: Tech stocks hit high scores on ominous day
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
"J&J Accuses Big Health Insurer of Helping Drain Its Drug Copay Funds; Pharmaceutical Company Claims Cigna Units Worked With SaveOn and Caused It to Pay More Than $100 Million in Copay Assistance Than It Would Have Otherwise" - WSJ
Wall Street Retreats As Treasuries Suffer Worst Week In Over A Year, Broadcom Soars, Bitcoin Rebounds: What's Driving Markets Friday?
Johnson & Johnson Options Trading: A Deep Dive Into Market Sentiment
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
"Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News